Print this page
 Email this page

 Connect with UMMC on:
 Twitter
 Facebook
 YouTube
iPhone

 Share this page:

Bookmark and Share

Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

 

Ask the Expert

Dr. Edelman’s Bio Image

Get answers to your Medical oncology for lung cancer questions.

Dr. Edelman’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

Video details

[ Flash player icon ] Please install flash player to see this video.

Cancer Center Virtual Tour

Click to take a virtual tour

Related Content


 

Mesothelioma (malignant) - Treatment

Alternative Names

Malignant mesothelioma

Treatment:

There is no cure. Untreated, the average malignant mesothelioma patient survives 9 months. It is a difficult cancer to treat.

Often the disease is too advanced for surgery. Chemotherapy or radiation may be used to reduce symptoms. Combining certain chemotherapy drugs may help decrease symptoms and improve survival, but it will not cure the cancer.

Consider participating in a clinical trial (test of new treatments), which may give you more treatment options.

Pain relief, oxygen, and other supportive treatments may also help relieve symptoms.

Support Groups:

You can ease the stress of illness by joining a support group where members share common experiences and problems.

See:

Expectations (prognosis):

The average survival time varies from 4 - 18 months. However, your outlook depends on:

  • The stage of the tumor
  • Your age and general health
  • Whether surgery is an option

Complications:

The tumor can quickly spread to other organs.

Calling your health care provider:

Call for an appointment with your health care provider if you have symptoms of malignant mesothelioma.

  • Reviewed last on: 9/4/2008
  • Sean O. Stitham, MD, private practice in Internal Medicine, Seattle, Washington; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

References

West SSD, Lee YCG. Management of malignant pleural mesothelioma. Clinics in Chest Medicine. 2006;27:335-354.

Camacho LH, Mora-Bowen A, Munden R, Smythe WR, OrdoƱez NG. Malignant mesothelioma: natural history, pathologic features and future therapies. Am J Med. 2007;120:e7-9.

Mason RJ, Murray J, VC Broaddus, Nadel J. Textbook of Respiratory Medicine. 3rd ed. Philadelphia, Pa: WB Saunders; 2005:1994-2002.

Grainger RC, Allison D, Adam, Dixon AK. Diagnostic Radiology: A Textbook of Medical Imaging. 4th ed. Orlando, Fl: Churchill Livingstone; 2001:339-341; 514-515.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com